The thesis
PanicFade v4 is a contrarian mean-reversion strategy built on a simple behavioural premise: negative headline shocks tend to be overreacted to and then revert toward fundamentals. It only acts when two conditions coincide — a sentiment reading below -0.4 and a name that is already technically oversold (RSI14 below 35 and trading under its 20-day SMA). It then sizes into the weakness, exiting on reversion (RSI14 back above 50 or a reclaimed SMA20) and hard-stopping on fresh lows under continued negativity, which it treats as a genuine fundamental break rather than noise.
The idea is grounded in recent literature on sentiment asymmetries and media-driven overreaction (arXiv:2509.11970 and corroborating work in JRFM/MDPI, 2025). The universe is deliberately conservative — 24 mega-cap, liquid names across tech, financials, healthcare, staples and energy — which suits a strategy that relies on eventual reversion rather than deep-value recovery.
Validation strength
This is where PanicFade v4 earns attention. The walk-forward validation passed on a demanding profile: 4 of 4 folds positive, an out-of-sample return of 21.7% with an OOS Sharpe of 2.44, a Probabilistic Sharpe Ratio of 0.985, and a Deflated Sharpe Ratio of 0.56 across 27 trials. The DSR figure matters most — it discounts the headline Sharpe for the number of configurations tried, and staying positive after 27 attempts is a meaningful guard against overfitting. Fold returns also improved monotonically (1.6% → 3.88% → 10.14% → 21.7%), suggesting the edge has held up in more recent regimes rather than decaying.
The backtest, in context
Over 1,233 days the full backtest returned 37.93% (final equity $13,793 from $10k), with a 62.88% win rate across 530 trades and a contained 9.3% max drawdown. Two caveats deserve honesty. First, the headline Sharpe of 0.96 is only modest — the flattering 2.44 belongs to the most recent fold, not the whole sample. Second, the CAGR is just 6.79%; the eye-catching total return is spread across nearly three-and-a-half years. Turnover of 5,807% also confirms this is a high-churn strategy, though fees stayed low ($530 total, no FX cost).
Recent activity: dormant by design
Live, the picture is quiet. The last executed trade was a 10-share buy of WMT at $103.12 on 28 August. Every scheduled run since — six sessions from 2 to 9 September — logged 0 executed, 0 rejected, with cash pinned at $8,958.54 (roughly 89% of the ~$10,018 book) against a single small position. Total equity has drifted mildly lower over that stretch.
This is not a malfunction; it is the strategy working as specified. With no names hitting the sentiment-and-oversold trigger, PanicFade v4 correctly does nothing. The risk is subtler: a strategy that fires only in panics can sit idle for long stretches, and its recent, strongest results coincide with a period that may not repeat. It is validated and patient — but investors should expect it to earn nothing until the next genuine selloff arrives.